Last update 21 Nov 2024
ISM-8207
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism QPCTL inhibitors(glutaminyl-peptide cyclotransferase like inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with ISM-8207A Phase 1, Open-label, Multicenter, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ISM8207 Monotherapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Lymphoid Malignancies
一项评价ISM8207治疗晚期实体瘤和复发/难治性B细胞淋巴瘤受试者的安全性、耐受性、药代动力学和初步疗效的I期、开放性、多中心、首次人体研究
[Translation] A Phase I, open-label, multicenter, first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ISM8207 in subjects with advanced solid tumors and relapsed/refractory B-cell lymphoma
100 Clinical Results associated with ISM-8207
Login to view more data
100 Translational Medicine associated with ISM-8207
Login to view more data
100 Patents (Medical) associated with ISM-8207
Login to view more data
100 Deals associated with ISM-8207
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | CN | 25 Apr 2024 | |
| B-Cell Lymphoma | Phase 1 | CN | 25 Apr 2024 | |
| B-cell lymphoma recurrent | Phase 1 | CN | 11 Apr 2024 | |
| B-cell lymphoma refractory | Phase 1 | CN | 11 Apr 2024 | |
| Solid tumor | Phase 1 | CN | 11 Apr 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free